Optimization of Docetaxel–Zedoary Turmeric Oil Magnetic Solid Lipid Nanoparticle Preparation by Central Composite Design-Response Surface Methodology
ASSAY and Drug Development Technologies · 2025
DOI: 10.1089/adt.2024.120 ↗Kurz gefasst
Fachartikel in der Zeitschrift ASSAY and Drug Development Technologies, 2025. Verfasst von Yujiao Hou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Qiqihar Medical University, Qiqihar, China. Hauptthemen laut MEDLINE: Docetaxel, Plant Oils, Antineoplastic Agents, Magnetite Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Qiqihar Medical University, Qiqihar, China.
- School of Medicine, Qilu Institute of Technology, Shandong, China.
- Department of Mammography, The Third Affiliated Hospital of Qiqihar Medical College, Qiqihar, China.
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China.
Zitieren
APA
Hou, Y., Zhao, Y., Liu, J., Bao, Y., Mosesmanaanye, N., Zhao, C., Li, W., & Hong, B. (2025). Optimization of Docetaxel–Zedoary Turmeric Oil Magnetic Solid Lipid Nanoparticle Preparation by Central Composite Design-Response Surface Methodology. ASSAY and Drug Development Technologies. https://doi.org/10.1089/adt.2024.120
Vancouver
Hou Y, Zhao Y, Liu J, Bao Y, Mosesmanaanye N, Zhao C, et al. Optimization of Docetaxel–Zedoary Turmeric Oil Magnetic Solid Lipid Nanoparticle Preparation by Central Composite Design-Response Surface Methodology. ASSAY and Drug Development Technologies. 2025. doi:10.1089/adt.2024.120
BibTeX
@article{Hou2025,
author = {Hou, Yujiao and Zhao, Yuesheng and Liu, Jun and Bao, Yanan and Mosesmanaanye, Njolibimi and Zhao, Chunjie and Li, Wenjing and Hong, Bo},
title = {Optimization of Docetaxel–Zedoary Turmeric Oil Magnetic Solid Lipid Nanoparticle Preparation by Central Composite Design-Response Surface Methodology},
journal = {ASSAY and Drug Development Technologies},
year = {2025},
doi = {10.1089/adt.2024.120}
}
EUVIMED